CLYM
Price
$1.30
Change
-$0.04 (-2.99%)
Updated
Apr 24 closing price
Capitalization
87.72M
24 days until earnings call
ELVN
Price
$18.30
Change
+$0.53 (+2.98%)
Updated
Apr 24 closing price
Capitalization
896.78M
13 days until earnings call
Ad is loading...

CLYM vs ELVN

Header iconCLYM vs ELVN Comparison
Open Charts CLYM vs ELVNBanner chart's image
Climb Bio
Price$1.30
Change-$0.04 (-2.99%)
Volume$110.08K
Capitalization87.72M
Enliven Therapeutics
Price$18.30
Change+$0.53 (+2.98%)
Volume$249.99K
Capitalization896.78M
CLYM vs ELVN Comparison Chart
Loading...
CLYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLYM vs. ELVN commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLYM is a Buy and ELVN is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (CLYM: $1.30 vs. ELVN: $18.30)
Brand notoriety: CLYM and ELVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLYM: 48% vs. ELVN: 91%
Market capitalization -- CLYM: $87.72M vs. ELVN: $896.78M
CLYM [@Biotechnology] is valued at $87.72M. ELVN’s [@Biotechnology] market capitalization is $896.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLYM’s FA Score shows that 1 FA rating(s) are green whileELVN’s FA Score has 0 green FA rating(s).

  • CLYM’s FA Score: 1 green, 4 red.
  • ELVN’s FA Score: 0 green, 5 red.
According to our system of comparison, ELVN is a better buy in the long-term than CLYM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLYM’s TA Score shows that 4 TA indicator(s) are bullish while ELVN’s TA Score has 5 bullish TA indicator(s).

  • CLYM’s TA Score: 4 bullish, 4 bearish.
  • ELVN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ELVN is a better buy in the short-term than CLYM.

Price Growth

CLYM (@Biotechnology) experienced а +3.17% price change this week, while ELVN (@Biotechnology) price change was +10.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

CLYM is expected to report earnings on Aug 19, 2025.

ELVN is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELVN($897M) has a higher market cap than CLYM($87.7M). ELVN YTD gains are higher at: -18.667 vs. CLYM (-27.778). CLYM has higher annual earnings (EBITDA): -24.57M vs. ELVN (-104.24M). ELVN has more cash in the bank: 313M vs. CLYM (193M). ELVN has less debt than CLYM: ELVN (0) vs CLYM (58K). CLYM (0) and ELVN (0) have equivalent revenues.
CLYMELVNCLYM / ELVN
Capitalization87.7M897M10%
EBITDA-24.57M-104.24M24%
Gain YTD-27.778-18.667149%
P/E RatioN/AN/A-
Revenue00-
Total Cash193M313M62%
Total Debt58K0-
TECHNICAL ANALYSIS
Technical Analysis
CLYMELVN
RSI
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 1 day ago
74%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 25 days ago
90%
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
CLYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JMVZX30.53N/A
N/A
JPMorgan Mid Cap Value R2
FBOGX8.54N/A
N/A
Templeton Global Smaller Comp R6
OEQIX7.63N/A
N/A
Oaktree Emerging Markets Equity I
LNGZX39.42N/A
N/A
Columbia Greater China Inst
PXSGX28.39N/A
N/A
Virtus KAR Small-Cap Growth I

CLYM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLYM has been loosely correlated with RLYB. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CLYM jumps, then RLYB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLYM
1D Price
Change %
CLYM100%
-2.99%
RLYB - CLYM
40%
Loosely correlated
+0.47%
ELVN - CLYM
36%
Loosely correlated
+2.98%
MNMD - CLYM
33%
Poorly correlated
+5.24%
CLDX - CLYM
32%
Poorly correlated
+0.77%
LRMR - CLYM
32%
Poorly correlated
+4.87%
More

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with ERAS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
+2.98%
ERAS - ELVN
50%
Loosely correlated
-1.41%
APGE - ELVN
49%
Loosely correlated
+1.42%
OCUL - ELVN
49%
Loosely correlated
+0.64%
CRNX - ELVN
48%
Loosely correlated
+3.15%
DNLI - ELVN
48%
Loosely correlated
+4.17%
More